Nothing Special   »   [go: up one dir, main page]

Mond et al., 1972 - Google Patents

SURFACE ANTIGENS OF IMMUNOCOMPETENT CELLS: III. IN VITRO STUDIES OF THE ROLE OF B AND T CELLS IN IMMUNOLOGICAL MEMORY

Mond et al., 1972

View PDF
Document ID
12573838194104195921
Author
Mond J
Takahashi T
Thorbecke G
Publication year
Publication venue
The Journal of Experimental Medicine

External Links

Snippet

The effect of preincubation with anti-θ or anti-mouse immunoglobulin (Ig) and complement (C') on immune responsiveness of spleen cells from BALB/c mice immunized with sheep erythrocytes (SE) was investigated. Both treatments greatly depressed the remaining ability …
Continue reading at pmc.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Similar Documents

Publication Publication Date Title
Cunningham et al. The asynchronous development of immunological memory in helper (T) and precursor (B) cell lines
Katz et al. Cell interactions between histoincompatible T and B lymphocytes. VII. Cooperative responses between lymphocytes are controlled by genes in the I region of the H-2 complex
Handman et al. Stage-specific, strain-specific, and cross-reactive antigens of Leishmania species identified by monoclonal antibodies
EP0097518B1 (en) Monoclonal antibody
Forman et al. Generation of cytotoxic lymphocytes in mixed lymphocyte reactions: I. specificity of the effector cells
Pierce et al. The allogeneic bisection of carrier-specific enhancement of monoclonal B-cell responses.
Kappler et al. Regulation of the immune response: I. Differential effect of passively administered antibody on the thymus-derived and bone marrow-derived lymphocytes
PT721469E (en) ANTI-GP39 ANTIBODIES AND THEIR USES2
Jennings et al. Evidence for separate subpopulations of B cells responding to T-independent and T-dependent immunogens
JPS645040B2 (en)
Unanue Thymus dependency of the immune response to hemocyanin: an evaluation of the role of macrophages in thymectomized mice
Segal et al. Specific blocking in vitro of antibody synthesis by affinity labelling reagents
Oldham et al. Cell‐mediated immune responsiveness of patients with acute lymphocytic leukemia in remission
Mond et al. SURFACE ANTIGENS OF IMMUNOCOMPETENT CELLS: III. IN VITRO STUDIES OF THE ROLE OF B AND T CELLS IN IMMUNOLOGICAL MEMORY
Morgan et al. Regulation of the immune response. I. The potentiation of in vivo and in vitro immune responses by Fc fragments
Eig et al. Complete inhibition of the expression of an idiotype by a mechanism of B-cell dominance.
Yamamoto et al. Regulatory functions of hapten-reactive helper and suppressor T lymphocytes. I. Detection and characterization of hapten-reactive suppressor T-cell activity in mice immunized with hapten-isologous protein conjugate
Schirrmacher et al. Cytotoxic immune cells with specificity for defined soluble antigens IV. Antibody as mediator of specific cytotoxicity
AU686134B2 (en) Soluble T-cell receptor alpha chain and derivatives used as prophylactic and therapeutic agents for autoimmune diseases
Chao et al. Specificity of antibodies secreted by hybridomas generated from activated B cells in the mesenteric lymph nodes of patients with inflammatory bowel disease.
Kalil et al. Role of class I and class II antigens in the allogenic stimulation: Class I and class II recognition in allogenic stimulation; blocking of MLR by monoclonal antibodies and F (ab′) 2 fragments
Unanue Antigen Binding Cells: II. Effect of Highly Radioactive Antigen on the Immunologic Function of Bone Marrow Cells
Kwak et al. Transfer of specific immunity to B-cell lymphoma with syngeneic bone marrow in mice: a strategy for using autologous marrow as an anti-tumor therapy
Morgan et al. “Hidden” cytotoxic antibodies that react with allogeneic cultured fetal and tumor cells contained in soluble immune complexes from normal human sera
Volk et al. The therapeutic efficacy of an anti-IL-2 receptor monoclonal antibody correlates with an increase in serum soluble IL-2 receptor levels